Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
27 November 2023 |
Main ID: |
NCT02303015 |
Date of registration:
|
25/11/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
|
Scientific title:
|
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors |
Date of first enrolment:
|
August 2014 |
Target sample size:
|
430 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02303015 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Denmark
| | | | | | | |
Contacts
|
Name:
|
Gedske Daugaard, MD DMSc |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Rigshospitalet, Denmark |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Danish citizen
- Diagnosed with germ cell cancer from 1984 to 2007
- Treated initially at a Danish hospital
- Treated with standard treatment regimens.
Exclusion Criteria:
- Treated initially at a foreign hospital
Age minimum:
15 Years
Age maximum:
N/A
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Germ Cell Cancer
|
Primary Outcome(s)
|
Renal toxicity (Identify genetic variations predicting renal toxicity)
[Time Frame: 1 year]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|